Cure My Disease

Don't miss your cure!

 Log in / Sign up

Texts and trackers aim to get diabetics out of their chairs

NCT ID NCT04219800

Completed Disease control Sponsor: Umeå University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether using activity trackers, text reminders, and short exercise videos could help people with type 2 diabetes reduce the time they spend sitting at work. Forty-six adults with type 2 diabetes who had mostly desk jobs took part. The goal was to see if these mobile health tools could lead to less sitting, more steps, and better overall health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
activity tracker armband, SMS reminders, and mobile video instructions
What this could lead to
If successful, this approach could offer a low-cost way to help people with type 2 diabetes reduce sitting time and improve health outcomes.
What could go wrong
This is a small, completed trial with only 46 participants, so results may not apply to everyone. The intervention focuses on behavior change, which can be hard to maintain long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2

Contacts and locations

Locations

  • Björkskatans Hälsocentral

    Luleå, Norrbotten County, Sweden

  • Clinical Research Centre

    Östersund, Sweden

  • Clinical Research Centre

    Umeå, Sweden

  • Hallsbergs hälsocentral

    Hallsberg, Sweden

  • Kärna Vårdcentral

    Linköping, Sweden

  • Torsviks Vårdcentral

    Stockholm, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.